BioLife Solutions, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 24 →InsidersNo open-market buys. 13 insiders sold $56.6M, 33 of 49 sales on a 10b5-1 plan.→HoldersBlackRock 13.0%Casdin Capital 9.5%Invesco 4.6%→PeersClosest companies: ANAB, WVE, JAZZ→
From the filings
Figures
- Revenue
- $102.8Mlast 12 months
- Net income
- $58.0Mlast 12 months
- Operating cash flow
- $17.9Mlast 12 months
- Cash and equivalents
- $24.0Mat the last balance sheet
- Total debt
- $0.00at the last balance sheet
- Shares outstanding
- 48.9M shareson issue